about
Signaling Pathways in Osteoclast DifferentiationHigh Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.DNA Demethylation Rescues the Impaired Osteogenic Differentiation Ability of Human Periodontal Ligament Stem Cells in High Glucose.Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling.RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146.Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.Integrin-Linked Kinase Regulates Bone Formation by Controlling Cytoskeletal Organization and Modulating BMP and Wnt Signaling in Osteoprogenitors.Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt.The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.The unfolded protein response in skeletal development and homeostasis.Pasteurella multocida Toxin Triggers RANKL-Independent Osteoclastogenesis.Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption.RBP-J and ITAM crosstalk.Dysregulated TGF-β signaling alters bone microstructure in a mouse model of Loeys-Dietz syndrome.Fluvastatin Inhibits Osteoclast Differentiation and Porphyromonas gingivalis Lipopolysaccharide-Induced Alveolar Bone Erosion in Mice.Ca2+-Dependent Regulation of NFATc1 via KCa3.1 in Inflammatory Osteoclastogenesis.The osteoclasts attach to the bone surface where the extracellular calcium concentration decreases.Clastic cells are absent around the root surface in pulp-exposed periapical periodontitis lesions in mice.Osteogenesis imperfecta and therapeutics.Essential Role of the a3 Isoform of V-ATPase in Secretory Lysosome Trafficking via Rab7 Recruitment.An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes.Paeoniflorin regulates osteoclastogenesis and osteoblastogenesis via manipulating NF-κB signaling pathway both in vitro and in vivo.Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice.Monocyte Subsets Have Distinct Patterns of Tetraspanin Expression and Different Capacities to Form Multinucleate Giant Cells.
P2860
Q26766637-6A405ECE-AA5E-434C-AC61-B45B1738CA77Q36162776-3B05C8B1-8761-4A41-B258-33243F2AA612Q36971547-8B5DAD75-E5FE-4439-9707-65744C673124Q36980431-5D8B3E30-65AC-4AEA-BEF8-64ADAB374582Q37377385-2D753957-7B9F-456E-A53D-C2FEC6AF7C4CQ37730637-AC5B4581-0E1B-44E8-BD24-25C273774FC8Q38700342-E864BEFD-B42C-498E-8827-C98BA707B11FQ38748841-3BE071A6-DE1E-4846-AA11-9B964DA60392Q38749702-5040B04C-77EB-4D6B-A9F0-27AA22F12B9CQ38751138-4D3177C5-E567-4E25-B5BA-D27EE796E617Q38784676-D8D24AD4-4968-4E72-97C3-F9BCF0E282BBQ40295736-2180DC6B-7AC4-46AA-8480-E108C6476F26Q42409435-BC73C913-537E-4294-B6AA-5A7A93B30994Q42552561-AB9B0F09-3D69-4AEC-B02D-BB2A8530CDF2Q46280563-AB9BF372-0860-4257-ABC9-64E3C36D3789Q46458661-1AF9315E-E19A-4BEC-B952-55F0E6FBC272Q47287626-6D2E366B-9477-4429-A9B2-ABAA990E4797Q51415353-8EDEB0FD-D1F0-4B68-B58B-2BE31B8ECFDEQ51767238-ED68C3D9-3004-4695-866E-3E9C72243926Q52655586-293A0046-A9C2-4DEF-A1A4-27506AC8E680Q52715407-4ED0945E-D71C-48F2-920B-8EE1632D5904Q55019978-E7C664EB-13A9-436A-8CDA-D0745FB47A93Q55344415-50E80029-8F50-4AC4-9626-03526539994EQ55413820-9C25F756-E5F1-4305-AB1D-E85F8BFF7FE9Q55437304-DE7E870C-3113-44BD-963F-FF81D02688FF
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Osteoclasts: New Insights
@ast
Osteoclasts: New Insights
@en
type
label
Osteoclasts: New Insights
@ast
Osteoclasts: New Insights
@en
prefLabel
Osteoclasts: New Insights
@ast
Osteoclasts: New Insights
@en
P2860
P356
P1433
P1476
Osteoclasts: New Insights
@en
P2093
P2860
P2888
P356
10.4248/BR201301003
P577
2013-03-29T00:00:00Z
P6179
1023521420